(Q44575158)

4 December 2017

Reduction of sleep-disordered breathing after physostigmine (English)

1 reference

4 December 2017

1 reference

Jan Hedner

1

1 reference

4 December 2017

Holger Kraiczi

series ordinal

2

1 reference

4 December 2017

Yuksel Peker

series ordinal

3

1 reference

4 December 2017

Paul Murphy

series ordinal

4

1 reference

4 December 2017

language of work or name

English

0 references

publication date

4 September 2003

1 reference

American Journal of Respiratory and Critical Care Medicine

4 December 2017

1 reference

4 December 2017

168

1 reference

4 December 2017

10

1 reference

4 December 2017

1246-1251

1 reference

Impact of brainstem sleep mechanisms on pharyngeal motor control

4 December 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200211-1344OC

Physical findings and the risk for obstructive sleep apnea. The importance of oropharyngeal structures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200211-1344OC

Temperature thresholds in the oropharynx of patients with obstructive sleep apnea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200211-1344OC

Determinants of ventilatory instability and variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200211-1344OC

Physostigmine alters onset but not duration of REM sleep in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200211-1344OC

Obstructive sleep apnea is related to a thalamic cholinergic deficit in MSA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200211-1344OC

Pharmacokinetics of physostigmine after intravenous, intramuscular and subcutaneous administration in surgical patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200211-1344OC

Pharmacokinetics and pharmacodynamics of physostigmine after intravenous administration in beagle dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200211-1344OC

Effects of physostigmine on brain acetylcholine content and release

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200211-1344OC

Relation of brain regional physostigmine concentration to cholinesterase activity and acetylcholine and choline levels in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200211-1344OC

Influence of the cholinergic agonist RS 86 on normal sleep: sex and age effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200211-1344OC

Upper airway collapsibility: the importance of gender and adiposity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200211-1344OC

Contribution of cholinergic systems to state-dependent modulation of respiratory control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200211-1344OC

Neurotransmitters in central respiratory control

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200211-1344OC

Nonvagal Modulation of Hypoglossal Neural Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200211-1344OC

Stimulation of minor salivary glands by intraoral treatment with the cholinesterase inhibitor physostigmine in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200211-1344OC

Surface tension forces in sleep apnea: the role of a soft tissue lubricant: a randomized double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200211-1344OC

Benefit of atrial pacing in sleep apnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200211-1344OC

10.1164/RCCM.200211-1344OC

21 January 2018

Identifiers

DOI

1 reference

4 December 2017

1 reference